Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)
China flag China · Delayed Price · Currency is CNY
14.86
+0.05 (0.34%)
Feb 4, 2026, 3:04 PM CST

SHE:002365 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
234.84320.41326.17274.7293.51114.2
Trading Asset Securities
687.31600.16630.1557.5454.02634.1
Cash & Short-Term Investments
922.15920.57956.27832.22547.53748.3
Cash Growth
4.77%-3.73%14.91%52.00%-26.83%49.05%
Accounts Receivable
134.82161.79171.53187.23332.27162.91
Other Receivables
9.346.146.338.1211.6310.57
Receivables
144.16167.93177.86195.35343.9173.48
Inventory
78.4193.569.9149.6145.7881.67
Other Current Assets
22.9316.669.5718.1828.6924.11
Total Current Assets
1,1681,1991,2141,1951,0661,028
Property, Plant & Equipment
909.13948.07953.611,022988.96989.6
Long-Term Investments
77.8974.5568.381.37115.2335.27
Goodwill
--0.528.778.778.77
Other Intangible Assets
77.7379.5682.3984.4987.9389.82
Long-Term Deferred Tax Assets
8.845.8411.269.739.949.37
Other Long-Term Assets
21.191.9317.4622.039.213.35
Total Assets
2,2622,3092,3472,4242,2862,164
Accounts Payable
121.26124.02160.65162.77114.9197.58
Accrued Expenses
31.9341.0740.0447.54740.67
Short-Term Debt
28.3739.5310.0140.0120.38122.35
Current Income Taxes Payable
7.277.067.840.612.372.25
Current Unearned Revenue
22.9819.2815.5911.7721.5319.82
Other Current Liabilities
20.6117.3823.1222.4687.1827.57
Total Current Liabilities
232.43248.34257.26285.13293.37310.24
Long-Term Unearned Revenue
6.077.468.511.3113.0514.2
Long-Term Deferred Tax Liabilities
8.6910.7533.0924.7422.5325.49
Total Liabilities
247.2266.55298.85321.17328.95349.92
Common Stock
294.68294.68294.68294.68294.68294.68
Additional Paid-In Capital
714.5714.44712.92712.78712.23691.12
Retained Earnings
982.49985.91953.42995.2854.85772.87
Treasury Stock
-40.48-24.18----3.79
Comprehensive Income & Other
25.2322.9422.8914.714.160.84
Total Common Equity
1,9761,9941,9842,0171,8661,756
Minority Interest
38.848.2864.3885.6391.0658.1
Shareholders' Equity
2,0152,0422,0482,1031,9571,814
Total Liabilities & Equity
2,2622,3092,3472,4242,2862,164
Total Debt
28.3739.5310.0140.0120.38122.35
Net Cash (Debt)
893.78881.04946.26792.2527.15625.95
Net Cash Growth
3.91%-6.89%19.45%50.28%-15.78%25.43%
Net Cash Per Share
3.072.993.212.691.842.17
Filing Date Shares Outstanding
289.15289.15294.68294.68294.68294.28
Total Common Shares Outstanding
289.15291.24294.68294.68294.68294.28
Working Capital
935.22950.32956.34910.22772.52717.31
Book Value Per Share
6.846.856.736.856.335.97
Tangible Book Value
1,8991,9141,9011,9241,7691,657
Tangible Book Value Per Share
6.576.576.456.536.005.63
Buildings
-581.93573.53546.87547.89526.88
Machinery
-1,3061,2681,2101,0831,039
Construction In Progress
-66.4126.1251.5543.074.47
Source: S&P Global Market Intelligence. Standard template. Financial Sources.